# Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study

> **NCT03635424** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Medtronic Cardiovascular** · enrollment: 150 (actual)

## Conditions studied

- Bicuspid Aortic Valve

## Interventions

- **DEVICE:** Medtronic TAVR Systems

## Key facts

- **NCT ID:** NCT03635424
- **Lead sponsor:** Medtronic Cardiovascular
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-10-30
- **Primary completion:** 2019-11-13
- **Final completion:** 2030-12
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03635424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03635424, "Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03635424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*